Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0X8MI
|
||||
Former ID |
DIB010051
|
||||
Drug Name |
Berupipam
|
||||
Synonyms |
NNC-22-0010
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Psychotic disorders [ICD9: 290-299; ICD10:F20-F29] | Discontinued in Phase 1 | [545634] | ||
Company |
Novo Nordisk A/S
|
||||
Structure |
Download2D MOL |
||||
Formula |
C19H19BrClNO2
|
||||
Canonical SMILES |
c1([C@@H]2c3c(cc(c(c3)O)Cl)CCN(C2)C)c2c(cc(c1)Br)CCO2
|
||||
CAS Number |
CAS 150490-85-0
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Dopamine D1 receptor | Target Info | Antagonist | [533594] | |
PANTHER Pathway | Dopamine receptor mediated signaling pathway | ||||
PathWhiz Pathway | Dopamine Activation of Neurological Reward System | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.